Patient Investigational New Drug (sIND) applications in the United States SAN FRANCISCO, CA / ACCESS Newswire / September 30, 2025 / Jaguar Health (NASDAQ:JAGX) today announced that Jaguar family ...
The US Food and Drug Administration will review evidence about the safety and efficacy of mifepristone, one of the drugs used ...
The vaccine advisory committee is scheduled to meet next week to review and make recommendations for this fall’s updated ...
The drug will now be produced by Evita Solutions LLC, which describes its mission as being to ‘normalize abortion’ ...
The Food and Drug Administration has launched a new transparency policy for the reporting of foodborne illness outbreak ...
Conservatives have criticized the abortion medication, particularly after it became available through telehealth.
Attorney General Nick Brown, along with 19 other attorneys general, has issued a joint statement affirming the safety and ...
BALA CYNWYD, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare ...
The U.S. Food and Drug Administration said that it has begun the daily publication of adverse event reports related to drugs and biological products. This marks a shift from the previous quarterly ...
The U.S. Food and Drug Administration is changing its policy on who should get COVID-19 shots, potentially limiting access to new vaccine formulations as they enter the market. New and updated jabs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback